loadpatents
name:-0.18365693092346
name:-0.2511248588562
name:-0.012644052505493
Pastan; Ira H. Patent Filings

Pastan; Ira H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pastan; Ira H..The latest application filed is for "cross species single domain antibodies targeting mesothelin for treating solid tumors".

Company Profile
12.75.77
  • Pastan; Ira H. - Chevy Chase MD
  • Pastan; Ira H. - Potomac MD
  • Pastan; Ira H. - Bethesda MD US
  • Pastan; Ira H - Potomac MD US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-mesothelin polypeptides and proteins
Grant 11,390,683 - Pastan , et al. July 19, 2
2022-07-19
Cross Species Single Domain Antibodies Targeting Mesothelin For Treating Solid Tumors
App 20220064324 - Ho; Mitchell ;   et al.
2022-03-03
Combination Therapy of Immunotoxin and Checkpoint Inhibitor
App 20210338811 - Bigner; Darell ;   et al.
2021-11-04
Combination therapy of immunotoxin and checkpoint inhibitor
Grant 11,065,332 - Bigner , et al. July 20, 2
2021-07-20
Anti-BCMA polypeptides and proteins
Grant 10,925,969 - Pastan , et al. February 23, 2
2021-02-23
Modified Pseudomonas Exotoxin A
App 20210024648 - Pastan; Ira H. ;   et al.
2021-01-28
M971 Chimeric Antigen Receptors
App 20200283522 - Orentas; Rimas J. ;   et al.
2020-09-10
Anti-mesothelin Polypeptides And Proteins
App 20200247901 - Kind Code
2020-08-06
Immunotoxins With Albumin Binding Domain
App 20200223937 - Pastan; Ira H. ;   et al.
2020-07-16
M971 chimeric antigen receptors
Grant 10,703,816 - Orentas , et al.
2020-07-07
Recombinant immunotoxin targeting mesothelin
Grant 10,683,362 - Pastan , et al.
2020-06-16
Modified Pseudomonas Exotoxin A
App 20200181280 - Pastan; Ira H. ;   et al.
2020-06-11
Human monoclonal antibodies specific for CD22
Grant 10,494,435 - Dimitrov , et al. De
2019-12-03
Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes
Grant 10,428,119 - Pastan , et al. October 1, 2
2019-10-01
M971 Chimeric Antigen Receptors
App 20190085078 - Orentas; Rimas J. ;   et al.
2019-03-21
Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
App 20180362659 - Bigner; Darell D. ;   et al.
2018-12-20
Anti-bcma Polypeptides And Proteins
App 20180318435 - Pastan; Ira H. ;   et al.
2018-11-08
Combination Therapy Of Immunotoxin And Checkpoint Inhibitor
App 20180311346 - Bigner; Darell ;   et al.
2018-11-01
Pseudomonas exotoxin A with less immunogenic B cell epitopes
Grant 10,111,927 - Pastan , et al. October 30, 2
2018-10-30
Dual specific immunotoxin for brain tumor therapy
Grant 10,072,084 - Bigner , et al. September 11, 2
2018-09-11
M971 chimeric antigen receptors
Grant 10,072,078 - Orentas , et al. September 11, 2
2018-09-11
Methods for using antibodies for 3' iso-LM1 and 3', 6'-iso-LD1tumor gangliosides
Grant 10,052,382 - Bigner , et al. August 21, 2
2018-08-21
Human bispecific EGFRvIII and CD3 antibody engaging molecules
Grant 10,053,514 - Bigner , et al. August 21, 2
2018-08-21
Anti-CD22 chimeric antigen receptors
Grant 9,868,774 - Orentas , et al. January 16, 2
2018-01-16
Pseudomonas Exotoxin A With Less Immunogenic T Cell And/or B Cell Epitopes
App 20170369535 - Pastan; Ira H. ;   et al.
2017-12-28
Mesothelin domain-specific monoclonal antibodies and use thereof
Grant 9,803,022 - Ho , et al. October 31, 2
2017-10-31
Pseudomonas exotoxin a with less immunogenic T cell and/or B cell epitopes
Grant 9,765,123 - Pastan , et al. September 19, 2
2017-09-19
Pseudomonas Exotoxin A With Less Immunogenic B Cell Epitopes
App 20170216398 - Pastan; Ira H. ;   et al.
2017-08-03
Human bispecific EGFRvIII antibody and CD3 engaging molecules
Grant 9,676,858 - Bigner , et al. June 13, 2
2017-06-13
Human Monoclonal Antibodies Specific For Cd22
App 20170145097 - Dimitrov; Dimiter S. ;   et al.
2017-05-25
Pseudomonas exotoxin A with less immunogenic B cell epitopes
Grant 9,657,066 - Pastan , et al. May 23, 2
2017-05-23
Human monoclonal antibodies specific for CD22
Grant 9,598,492 - Dimitrov , et al. March 21, 2
2017-03-21
Modified Pseudomonas Exotoxin A
App 20170051072 - Pastan; Ira H. ;   et al.
2017-02-23
Dual Specific Immunotoxin for Brain Tumor Therapy
App 20170051064 - Bigner; Darell D. ;   et al.
2017-02-23
Dual specific immunotoxin for brain tumor therapy
Grant 9,492,564 - Bigner , et al. November 15, 2
2016-11-15
Antibodies for Tumor Gangliosides
App 20160272730 - Bigner; Darell ;   et al.
2016-09-22
Antibody for 3'-isoLM1 and 3',6'-iso-LD1 gangliosides
Grant 9,441,048 - Bigner , et al. September 13, 2
2016-09-13
Mesothelin antibodies and methods for eliciting potent antitumor activity
Grant 9,416,190 - Ho , et al. August 16, 2
2016-08-16
Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof
App 20160229919 - Ho; Mitchell ;   et al.
2016-08-11
Mesothelin domain-specific monoclonal antibodies and use thereof
Grant 9,409,992 - Ho , et al. August 9, 2
2016-08-09
Pseudomonas Exotoxin A With Less Immunogenic T Cell And/or B Cell Epitopes
App 20160215025 - Pastan; Ira H. ;   et al.
2016-07-28
Immunogenic POTE peptides and methods of use
Grant 9,394,352 - Berzofsky , et al. July 19, 2
2016-07-19
Modified Pseudomonas exotoxin A
Grant 9,388,222 - Pastan , et al. July 12, 2
2016-07-12
Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules
App 20160168263 - Bigner; Darell D. ;   et al.
2016-06-16
Anti-mesothelin chimeric antigen receptors
Grant 9,359,447 - Feldman , et al. June 7, 2
2016-06-07
Human Monoclonal Antibodies Specific For Cd22
App 20160145338 - Dimitrov; Dimiter S. ;   et al.
2016-05-26
Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes
Grant 9,346,859 - Pastan , et al. May 24, 2
2016-05-24
Human monoclonal antibodies specific for CD22
Grant 9,279,019 - Dimitrov , et al. March 8, 2
2016-03-08
Pseudomonas Exotoxin A With Less Immunogenic B Cell Epitopes
App 20160046677 - Pastan; Ira H. ;   et al.
2016-02-18
Bispecific EGFRvIII x CD3 antibody engaging molecules
Grant 9,249,217 - Bigner , et al. February 2, 2
2016-02-02
Anti-Podoplanin Antibodies and Methods of Use
App 20150368353 - BIGNER; Darell ;   et al.
2015-12-24
Pseudomonas exotoxin A with less immunogenic B cell epitopes
Grant 9,206,240 - Pastan , et al. December 8, 2
2015-12-08
Immunogenic peptides and methods of use
Grant 9,175,057 - Schlom , et al. November 3, 2
2015-11-03
M971 Chimeric Antigen Receptors
App 20150299317 - Orentas; Rimas J. ;   et al.
2015-10-22
Mesothelin Antibodies And Methods For Eliciting Potent Antitumor Activity
App 20150274836 - Ho; Mitchell ;   et al.
2015-10-01
Mesothelin Domain-specific Monoclonal Antibodies And Use Thereof
App 20150252118 - Ho; Mitchell ;   et al.
2015-09-10
Antibodies and immunotoxins that target human glycoprotein NMB
Grant 9,115,196 - Kuan , et al. August 25, 2
2015-08-25
HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES
App 20150132306 - Bigner; Darell ;   et al.
2015-05-14
Modified Pseudomonas Exotoxin A
App 20150099707 - Pastan; Ira H. ;   et al.
2015-04-09
Anti-mesothelin Chimeric Antigen Receptors
App 20150031624 - Feldman; Steven A. ;   et al.
2015-01-29
Pseudomonas exotoxin a with reduced immunogenicity
Grant 8,936,792 - Pastan , et al. January 20, 2
2015-01-20
Immunogenic Pote Peptides And Methods Of Use
App 20150010590 - Berzofsky; Jay A. ;   et al.
2015-01-08
Mutated Pseudomonas exotoxins with reduced antigenicity
Grant 8,907,060 - Pastan , et al. December 9, 2
2014-12-09
Dual Specific Immunotoxin for Brain Tumor Therapy
App 20140322248 - BIGNER; Darell ;   et al.
2014-10-30
Immunogenic POTE peptides and methods of use
Grant 8,871,902 - Berzofsky , et al. October 28, 2
2014-10-28
Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes
Grant 8,871,906 - Pastan , et al. October 28, 2
2014-10-28
Immunogenic Epitopes Of Ngep Antigen
App 20140287029 - Schlom; Jeffrey ;   et al.
2014-09-25
Anti-cd22 Chimeric Antigen Receptors
App 20140274909 - Orentas; Rimas J. ;   et al.
2014-09-18
Pseudomonas Exotoxin A With Less Immunogenic B Cell Epitopes
App 20140213529 - Pastan; Ira H. ;   et al.
2014-07-31
Recombinant Immunotoxin Targeting Mesothelin
App 20140154248 - Pastan; Ira H. ;   et al.
2014-06-05
Pseudomonas Exotoxin A With Less Immunogenic T Cell And/or B Cell Epitopes
App 20140094417 - Pastan; Ira H. ;   et al.
2014-04-03
Anti-podoplanin Antibodies And Methods Of Use
App 20140017266 - Bigner; Darell ;   et al.
2014-01-16
Antibodies For Tumor Gangliosides
App 20140010829 - Bigner; Darell ;   et al.
2014-01-09
Human Monoclonal Antibodies Specific For Cd22
App 20130315921 - Dimitrov; Dimiter S. ;   et al.
2013-11-28
Human monoclonal antibodies specific for CD22
Grant 8,591,889 - Dimitrov , et al. November 26, 2
2013-11-26
Antibodies and Immunotoxins that Target Human Glycoprotein NMB
App 20130245244 - KUAN; Chien-Tsun ;   et al.
2013-09-19
Immunogenic Peptides of Xage-1
App 20130171178 - Berzofsky; Jay A. ;   et al.
2013-07-04
Antibodies and immunotoxins that target human glycoprotein NMB
Grant 8,445,216 - Kuan , et al. May 21, 2
2013-05-21
Immunogenic Pote Peptides And Methods Of Use
App 20130039936 - Berzofsky; Jay A. ;   et al.
2013-02-14
Dual Specific Immunotoxin for Brain Tumor Therapy
App 20130022598 - Bigner; Darell ;   et al.
2013-01-24
Human anti-mesothelin monoclonal antibodies
Grant 8,357,783 - Dimitrov , et al. January 22, 2
2013-01-22
Pseudomonas Exotoxin A With Reduced Immunogenicity
App 20120263674 - Pastan; Ira H. ;   et al.
2012-10-18
Mutated Anti-cd22 Antibodies With Increased Affinity To Cd22-expressing Leukemia Cells
App 20120258106 - Pastan; Ira H ;   et al.
2012-10-11
Antibodies And Immunotoxins That Target Human Glycoprotein Nmb
App 20120122121 - KUAN; Chien-Tsun ;   et al.
2012-05-17
Antibodies and immunotoxins that target human glycoprotein NMB
Grant 8,039,593 - Kuan , et al. October 18, 2
2011-10-18
Mutated anti-cd22 antibodies and immunoconjugates
Grant 7,982,011 - Pastan , et al. July 19, 2
2011-07-19
Immunogenic Peptides And Methods Of Use
App 20110165117 - Schlom; Jeffrey ;   et al.
2011-07-07
Immunogenic peptides and methods of use
Grant 7,910,692 - Schlom , et al. March 22, 2
2011-03-22
Mutated Anti-cd22 Antibodies With Increased Affinity To Cd22-expressing Leukemia Cells
App 20110065185 - Pastan; Ira H. ;   et al.
2011-03-17
Gene expressed in prostate cancer and methods of use
Grant 7,897,355 - Pastan , et al. March 1, 2
2011-03-01
Human Anti-mesothelin Monoclonal Antibodies
App 20110020361 - Dimitrov; Dimiter S. ;   et al.
2011-01-27
Human Monoclonal Antibodies Specific For Cd22
App 20110020344 - Dimitrov; Dimiter S. ;   et al.
2011-01-27
Gene expressed in prostate cancer and methods of use
Grant 7,816,087 - Pastan , et al. October 19, 2
2010-10-19
Deletions In Domain Ii Of Pseudomonas Exotoxin A That Remove Immunogenic Epitopes
App 20100215656 - Pastan; Ira H. ;   et al.
2010-08-26
Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
Grant 7,709,252 - Pastan , et al. May 4, 2
2010-05-04
Anti-Tumor Antibodies
App 20100047164 - Bigner; Darell ;   et al.
2010-02-25
Dual Specific Immunotoxin for Brain Tumor Therapy
App 20090269343 - Bigner; Darell ;   et al.
2009-10-29
Antibodies And Immunotoxins That Target Human Glycoprotein Nmb
App 20090252750 - Kuan; Chien-Tsun ;   et al.
2009-10-08
Gene Expressed In Prostate Cancer And Methods Of Use
App 20090202552 - Pastan; Ira H. ;   et al.
2009-08-13
Mutated pseudomonas exotoxins with reduced antigenicity
App 20090142341 - Pastan; Ira H. ;   et al.
2009-06-04
Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric point
Grant 7,521,054 - Pastan , et al. April 21, 2
2009-04-21
Anti-mesothelin antibodies useful for immunological assays
App 20090047211 - Pastan; Ira H. ;   et al.
2009-02-19
Immunogenic Peptides And Methods Of Use
App 20090035266 - Schlom; Jeffrey ;   et al.
2009-02-05
Mutated Anti-CD22 Antibodies With Increased Affinity To CD22-Expressing Leukemia Cells
App 20090004734 - Pastan; Ira H. ;   et al.
2009-01-01
Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins
Grant 7,470,775 - Pastan , et al. December 30, 2
2008-12-30
Antibodies, Including Fv Molecules, And Immunoconjugates Having High Binding Affinity For Mesothelin And Methods For Their Use
App 20080261245 - Pastan; Ira H. ;   et al.
2008-10-23
Polymer-Linked Pseudomonas Exotoxin Immunotoxin
App 20080125363 - Filpula; David Ray ;   et al.
2008-05-29
Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
Grant 7,368,110 - Pastan , et al. May 6, 2
2008-05-06
Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
Grant 7,355,012 - Pastan , et al. April 8, 2
2008-04-08
Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
App 20070248972 - Pastan; Ira H. ;   et al.
2007-10-25
Mutated anti-cd22 antibodies and immunoconjugates
App 20070189962 - Pastan; Ira H. ;   et al.
2007-08-16
Elisa assay of serum soluble cd22 to assess tumor burnden/relapse in subjects with leukemia and lymphoma
App 20050244828 - Kreitman, Robert J. ;   et al.
2005-11-03
Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
App 20050214304 - Pastan, Ira H. ;   et al.
2005-09-29
Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
App 20050118182 - Pastan, Ira H ;   et al.
2005-06-02
Gene expressed in breast cancer and methods of use
App 20050053988 - Pastan, Ira H. ;   et al.
2005-03-10
Gene expressed in prostate cancer and methods of use
App 20040241702 - Pastan, Ira H. ;   et al.
2004-12-02
Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use
Grant 6,809,184 - Pastan , et al. October 26, 2
2004-10-26
Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point
App 20040091489 - Pastan, Ira H. ;   et al.
2004-05-13
Methods of making recombinant disulfide-stabilized polypeptide fragments having binding specificity
Grant 6,558,672 - Pastan , et al. May 6, 2
2003-05-06
Recombinant disulfide-stabilized polypeptide fragments having binding specificity
Grant 6,147,203 - Pastan , et al. November 14, 2
2000-11-14
Recombinant antibody-toxin fusion protein
Grant 5,863,745 - Fitzgerald , et al. January 26, 1
1999-01-26
Recombinant pseudomonas exotoxin with increased activity
Grant 5,854,044 - Pastan , et al. December 29, 1
1998-12-29
Recombinant pseudomonas exotoxin with increased activity
Grant 5,821,238 - Pastan , et al. October 13, 1
1998-10-13
Recombinant disulfide-stabilized polypeptide fragments having binding specificity
Grant 5,747,654 - Pastan , et al. May 5, 1
1998-05-05
Fusion proteins comprising circularly permuted ligands
Grant 5,635,599 - Pastan , et al. June 3, 1
1997-06-03
Recombinant pseudomonas exotoxin with increased activity
Grant 5,602,095 - Pastan , et al. February 11, 1
1997-02-11
Monoclonal antibodies to prostate cells
Grant 5,489,525 - Pastan February 6, 1
1996-02-06
Recombinant chimeric proteins deliverable across cellular membranes into cytosol of target cells
Grant 5,328,984 - Pastan , et al. July 12, 1
1994-07-12
Compositions for clones containing DNA sequences associated with multidrug resistance in human cells
Grant 5,206,352 - Roninson , et al. April 27, 1
1993-04-27
Anti-human ovarian cancer immunotoxins and methods of use thereof
Grant 4,958,009 - Bjorn , et al. * September 18, 1
1990-09-18
Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects
Grant 4,892,827 - Pastan , et al. January 9, 1
1990-01-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed